Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Small Nerve Fiber Pathology in Critical Illness

  • Nicola Latronico ,

    nicola.latronico@med.unibs.it

    Affiliation Department of Anesthesia and Critical Care Medicine, Section of Neuroanesthesia and Neurocritical Care, University of Brescia at Spedali Civili, Brescia, Italy

  • Massimiliano Filosto,

    Affiliation Department of Clinical Neurology, Section for Neuromuscular Diseases and Neuropathies, University of Brescia at Spedali Civili, Brescia, Italy

  • Nazzareno Fagoni,

    Affiliation Department of Anesthesia and Critical Care Medicine, Section of Neuroanesthesia and Neurocritical Care, University of Brescia at Spedali Civili, Brescia, Italy

  • Laura Gheza,

    Affiliation Department of Anesthesia and Critical Care Medicine, Section of Neuroanesthesia and Neurocritical Care, University of Brescia at Spedali Civili, Brescia, Italy

  • Bruno Guarneri,

    Affiliation Department of Clinical Neurophysiology, University of Brescia at Spedali Civili, Brescia, Italy

  • Alice Todeschini,

    Affiliation Department of Clinical Neurology, Section for Neuromuscular Diseases and Neuropathies, University of Brescia at Spedali Civili, Brescia, Italy

  • Raffaella Lombardi,

    Affiliation Neuromuscular Diseases Unit, “Carlo Besta” Neurological Institute, IRCCS Foundation, Milan, Italy

  • Alessandro Padovani,

    Affiliation Department of Clinical Neurology, Section for Neuromuscular Diseases and Neuropathies, University of Brescia at Spedali Civili, Brescia, Italy

  • Giuseppe Lauria

    Affiliation Neuromuscular Diseases Unit, “Carlo Besta” Neurological Institute, IRCCS Foundation, Milan, Italy

Abstract

Background

Degeneration of intraepidermal nerve fibers (IENF) is a hallmark of small fiber neuropathy of different etiology, whose clinical picture is dominated by neuropathic pain. It is unknown if critical illness can affect IENF.

Methods

We enrolled 14 adult neurocritical care patients with prolonged intensive care unit (ICU) stay and artificial ventilation (≥ 3 days), and no previous history or risk factors for neuromuscular disease. All patients underwent neurological examination including evaluation of consciousness, sensory functions, muscle strength, nerve conduction study and needle electromyography, autonomic dysfunction using the finger wrinkling test, and skin biopsy for quantification of IENF and sweat gland innervation density during ICU stay and at follow-up visit. Development of infection, sepsis and multiple organ failure was recorded throughout the ICU stay.

Results

Of the 14 patients recruited, 13 (93%) had infections, sepsis or multiple organ failure. All had severe and non-length dependent loss of IENF. Sweat gland innervation was reduced in all except one patient. Of the 7 patients available for follow-up visit, three complained of diffuse sensory loss and burning pain, and another three showed clinical dysautonomia.

Conclusions

Small fiber pathology can develop in the acute phase of critical illness and may explain chronic sensory impairment and pain in neurocritical care survivors. Its impact on long term disability warrants further studies involving also non-neurologic critical care patients.

Introduction

Survivors of critical illness may suffer from prolonged disability [1]. Several causes contribute to this so-called “post-intensive care syndrome”, which is defined as new or worsening impairment in physical, cognitive, or mental health status arising after critical illness and persisting beyond acute care hospitalization [2]. Critical illness polyneuropathy affects sensory and motor fibers innervating limb and respiratory muscles [3] and is a prominent cause of persisting physical disability [4], leading to difficulty in weaning the patient from mechanical ventilation and flaccid tetraparesis [5]. Sensory nerve impairment is usually reported after intensive care unit (ICU) discharge [5,6]. Stocking and glove sensory loss, feeling of cool extremities, numbness, tingling, and neuropathic pain symptoms including hyperalgesia and burning have been described at long-term follow-up of ICU survivors [5,6]. In some patients, pain can be extremely intense, precluding effective rehabilitation [7]. In a recent series of 16 patients with acute respiratory distress syndrome evaluated at 6 to 24 months after ICU discharge, 6 patients reported variable combinations of pain, numbness, tingling, diffuse weakness, cool extremities, and impaired exercise ability [6] in the absence of abnormalities at nerve conduction study (NCS). The lack of correlation between clinical and electrophysiological findings suggested a small fiber neuropathy [6]; however, skin biopsy, which is required to document the degeneration of intraepidermal nerve fibers (IENF) and to define the diagnosis [8], was not performed and therefore the hypothesis could not be confirmed.

Degeneration of IENF has been described in small fiber neuropathy (SFN) of different etiology [9,10] and in other neuropathies dominated by neuropathic pain, including those with predominantly large fiber involvement such as Guillain-Barré syndrome [11-14] and chronic demyelinating polyradiculoneuropathy [15]. Most recently, small fiber dysfunction has been also described in fibromyalgia [16]. The diagnosis of SFN is confirmed by the quantification of IENF density at the distal site of the leg, based on age and gender-adjusted normative reference values [17]. When a more diffuse and non-length depended process is suspected, such as in sensory neuronopathies [18], or in acute or chronic demyelinating neuropathies [15,19], the IENF density should be examined also at a proximal site of the body, such as the thigh or the trunk.

We hypothesized that critically ill patients may suffer from small nerve fiber pathology as part of the generalized inflammatory process leading to multiple organ dysfunctions and failures. To address this hypothesis, we prospectively monitorized organ function and performed skin biopsy during the ICU stay, and evaluated the survived patients at follow-up with focused neurological examination. Our results provide the first-ever evidence that critical illness causes also small nerve fiber degeneration since the early phases of the disease.

Materials and Methods

Critically ill neurologic patients admitted to the Neurocritical Care Unit of the University of Brescia at the Spedali Civili of Brescia, Italy, from September 1, 2011 to May 1, 2012 were consecutively recruited. Inclusion criteria were age ≥18 years, ICU stay ≥ 3 days, and need of either invasive or non-invasive ventilatory support. Criteria for exclusion were ascertained after discussion with patient’s family physician and family members, and after careful investigation of the clinical charts of previous hospital admissions. Exclusion criteria included the following: any previously known neuromuscular disease or condition at risk for peripheral neuropathy, such as diabetes, systemic diseases with renal, hepatic or thyroid dysfunction, alcohol abuse, HIV or hepatitis C infection, hematological diseases or monoclonal gammopathy of uncertain significance, vitamin B12 deficiency, connective tissue diseases (e.g. Sjögren syndrome), malignancies, previous or current treatment with neurotoxic drugs (e.g. antineoplastic or anti-arrhythmic drugs). We also excluded patients with chronic pain, those in terminal conditions and those in whom skin biopsy could not be taken or electrophysiological investigations of peripheral nerves and muscles were not feasible (e.g. coagulation disorders, plasters, limb amputation, limb edema, etc.) [20].

Ethics statement

The study was approved by the Ethics Committee of the University of Brescia at Spedali Civili (CRitical Illness Neuropathy of Epidermal fibers - CRINE study doc n.371/gt). Because all patients had brain injury and altered consciousness at ICU admission, the Ethics Committee permitted to use waived consent. In fact, the definition of the legal representative, or surrogate, of adult temporarily incapacitated ICU patients is absent in Italy [21]. Detailed written information was provided to the family members about the study protocol, the need for and safety of minimally invasive skin biopsy and the need of follow-up visits. At follow-up, written informed consent was obtained from the patients if they had regained their mental competency. All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki.

General, neurological, and electrophysiological assessment

During the ICU stay, patients were followed daily for the development of sepsis or multiple organ failure (MOF). Sepsis was defined according to current recommendations as the presence of both infection and systemic inflammatory response [22]. MOF was diagnosed as the evidence of two or more organ failures according to the sequential organ failure assessment score [23].

As critically ill patients often develop acute sensory-motor axonal polyneuropathy and/or myopathy, we performed nerve conduction studies (NCS) and needle electromyography (EMG). We adopted currently recommended criteria to diagnose critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) [3] using conventional techniques. Manual muscle strength testing was not possible during the ICU stay due to the altered consciousness of patients. Hence, we defined CIP and CIM as “probable” based on previously proposed criteria [3].

At follow-up, all patients underwent neurological examination including evaluation of consciousness, sensory functions, and muscle strength when permitted by the patient clinical conditions. Signs suggestive of autonomic dysfunction (e.g. abnormal sweating, lacrimation and/or salivation; gastrointestinal, bladder, and sexual disorders; orthostatic hypotension) were recorded. The finger wrinkling test was recorded after immersion of the right hand in a bucket filled with water at 40 °C and used to investigate sympathetic peripheral dysautonomia [24]. The degree of skin wrinkling at the fingertip was assessed at baseline and after 5, 15, and 30 minutes, and graded using a semi-quantitative 5-point clinical scale. We scored 0 in case of absent wrinkling, 1 when the skin was not completely smooth, 2 when two or less lines of wrinkling were seen, 3 when three or more lines of wrinkling were seen, and 4 when wrinkling completely distorted the pulp of the fingertip. The scores from 0 to 2 were considered abnormal (e.g. peripheral dysautonomia), whereas scores ≥3 were considered normal [25]. Severity of spontaneous and evoked pain (tactile allodynia and hyperalgesia) was graded using the 11-point Likert numerical rating score (NRS).

The modified Rankin Scale (mRS) was used to categorize the outcome as follow: mRS; 1= no symptoms; 2 or 3= moderate disability, able to walk but unable to perform all activities independently; 4= moderate-to-severe disability, unable to walk independently; 5= severe disability, bed-bound; 6= dead.

Skin biopsy

Skin biopsies were performed with a minimally invasive technique [8] as soon as the general condition stabilized (e.g. when there was no evidence of intracranial hypertension; coagulation disorders; hemodynamic instability requiring inotropic support; respiratory failure requiring mandatory mechanical ventilation; kidney insufficiency requiring dialysis; fever or sepsis). Biopsies were taken using a 3-mm disposable punch, after local anesthesia with 2% lidocaine under sterile technique, at the distal site of the leg (10 cm above the lateral malleolus within the territory of the sural nerve) and at the proximal site on the thigh (20 cm below the iliac spine). Specimens were immediately fixed for 24 hours at 4°C, cryoprotected, and shipped to the Skin Biopsy Laboratory at the “Carlo Besta” Neurological Institute of Milan, Italy, to be processed. Three sections randomly chosen from each sample were immunoassayed with polyclonal anti-protein gene product (PGP) 9.5 antibodies (Biogenesis, Poole, Dorset, UK; 1:1000) using the free-floating protocol for bright-field immunohistochemistry previously described [26]. The linear density of IENF was calculated according to current guidelines [17]. Densities from patients’ distal leg biopsy samples were compared with age- and gender-adjusted normative values [17], whereas those from the proximal thigh were compared with archive normative values [9]. Sweat gland innervation was assessed using a semi-quantitative approach comparing the density of PGP9.5-positive fibers around ducts with archive biopsy sections from healthy subjects. Sweat gland were considered completely or partially denervated when no or only sparse PGP 9.5-positive fibers, respectively, were recognizable.

Data presentation

Data were reported as means and standard deviation (SD) when normally distributed, and median with 25 to 75% quartiles (interquartile range, IQR) when not normally distributed.

Results

During the study period, 246 patients were excluded because the ICU stay was less than 3 days (158 patients), or patients had diabetes (41 patients), malignancy (19 patients), alcohol abuse (7 patients), renal insufficiency (4 patients), liver cirrhosis (4 patients), pre-existing neuromuscular disorders (3 patients), hepatitis C infection (2 patients), patients were in terminal condition (7 patients) or skin biopsy was not feasible (1 patients). Fourteen consecutive patients (5.7%) were eventually recruited.

Demographic characteristics, admission diagnoses, NCS, EMG, and skin biopsy findings are detailed in Table 1. Median duration of mechanical ventilation was 12 days (IQR 8-15). Median ICU stay was 17 days (IQR 11-18). Thirteen patients developed sepsis during the ICU stay, predominantly related to respiratory, urinary, and bloodstream infections. Only one did not have proven infection despite persistent fever.

PatientAdmission diagnosisAdmission GCSICU complicationsNerve conduction studyIENF per mm (lower limit of normality)  Sweat gland innervation
No.Gender, ageEye-Motor-Verbal  proximal thighdistal leg
1M, 55 ySubarachnoid hemorrhage1-6-1VAP, UTI, CRBSI, sepsisAxonal sensory-motor neuropathy4.3 (12.8)2.6 (3.5)Reduced
2M, 48 yHead trauma2-5-1VAP, sepsisMyopathy5.6 (12.8)2.7 (4.4)Reduced
3M, 74 yHemorrhagic shock, hypotensive encephalopathy2-1-1VAP, septic shockAxonal sensory-motor neuropathy0 (12.8)1.2 (2.1)Reduced
4M, 56 ySubarachnoid hemorrhage1-1-1VAP, sepsis, SEAxonal sensory-motor neuropathy6.3 (12.8)2.6 (3.5)Reduced
5F, 47 yIntracerebral hemorrhage3-6-1VAP, sepsisAxonal sensory-motor neuropathy6.3 (12.8)1.7 (5.7)Reduced
6M, 56 ySubarachnoid hemorrhage1-5-1VAP, UTI, CRBSI, sepsis, MOF, DCI-CIMyopathy7.2 (12.8)1.9 (3.5)Normal
7F, 66 yIschemic stroke4-5-1VAP, CRBSI, sepsis, MOFMyopathy1.6 (12.8)0.2 (3.2)Reduced
8F, 77 ySubarachnoid hemorrhage3-6-3EVD-meningitis, sepsis, MOFMyopathy7.0 (12.8)1.4 (2.2)Reduced
9M, 62 ySubarachnoid hemorrhage3-6-1Central hyperthermia, DCI-CINormal findings0 (12.8)0 (2.8)Reduced
10F, 71 yNeurosurgery (pituitary adenoma)3-6-2Cerebral ischemiaMyopathy2.2 (12.8)0.6 (2.2)not available
11M, 45 yCranio-facial trauma1-5-2VAP, septic shockNormal findings2.5 (12.8)1.7 (4.4)Reduced
12F, 77 ySubdural abscess1-5-1SepsisMyopathy3.0 (12.8)1.7 (2.2)Reduced
13F, 41 ySubarachnoid hemorrhage1-3-1Meningitis, VAP, sepsisMyopathy4.6 (12.8)3.7 (5.7)Reduced
14F, 58 yNeurosurgery (meningioma)3-6-1UTI, sepsisMyopathy1.1 (12.8)1.3 (4.3)Reduced

Table 1. Patients’ characteristics.

GCS, Glasgow Coma Scale. ICU, intensive care unit. IENFD, intraepidermal nerve fibers; mRS, modified Rankin Scale: 0= no symptoms; 1= significant disability despite symptoms; 2, 3= mild or moderate disability; 4= moderate-to-severe disability; 5= severe disability; 6=dead. VAP: ventilator-associated pneumonia; UTI: urinary tract infection; CRBSI: catheter-related bloodstream infection. SE: status epilepticus. EVD-meningitis: meningitis associated with external ventricular drainage. DCI-CI: delayed cerebral ischemia with cerebral infarction.
CSV
Download CSV

NCS study and EMG were performed on median ICU day 8 (IQR 7-14 days) and revealed CIM in 8 patients, CIP in 4 patients, and normal findings in 2 patients.

Skin biopsies were obtained on median ICU day 22 (IQR 18-24 days). All patients showed a severe and non-length dependent degeneration of IENF with densities below normal values at both distal leg and proximal thigh (table 1). Epidermal and dermal nerves showed diffuse degenerative changes with fragmented and weak staining. Sweat glands were severely denervated in all except one patient with CIM (Figure 1). There were no complications associated with skin biopsies.

thumbnail
Figure 1. Skin biopsy.

Bright field immunohistochemical studies (polyclonal anti-protein gene product 9.5 antibody; Ultraclone, Wellow, Isle of Wight, UK) in sections of skin biopsy taken at the proximal thigh (A) and distal site of the leg (B) with a sweat gland (C) in patient no. 7, and at the proximal thigh (D) and distal site of the leg (E) with a sweat gland (F) in a healthy subject.

Arrows indicate intra-epidermal nerve fibers and arrowheads indicate dermal nerve bundles. The patient, with normal nerve conduction study findings and myopathy at needle electromyography, showed a severe depletion of intra-epidermal nerve fibers and a severe reduction in the density of dermal nerve bundles, whose staining was fragmented and weaker due to axonal degeneration. Sweat gland innervation was also markedly reduced. Original magnification 40x. Bar is 50 µm in all images.

https://doi.org/10.1371/journal.pone.0075696.g001

Two patients died after ICU discharge. At follow-up, 2 patients regained full functional independence, 1 patient had mild disability, 4 patients had moderate-to-severe disability, and 5 patients had severe disability (table 2). Seven patients (no. 2, 5, 7, 8, 11, 12, 14) were available for follow-up examination and three of them complained of sensory loss and burning pain (no. 2, 8 and 12). Pain was diffuse, and in one patient (no. 2) it was so severe to interfere with effective physical rehabilitation. Intriguingly, all these 3 patients had acute myopathy with no evidence of large fiber sensory neuropathy at NCS. Their sensory symptoms likely reflected a small fiber neuropathy as diagnosed by skin biopsy.

PatientSensory signsMotor signsDysautonomic signsFinger wrinkling testFollow-up (days after ICU discharge)GCSOutcome mRS
No.Eye-Motor-Verbal
1NANANANA6 months/6
2Sensory loss, severe paroxysmal pain (NRS 9/10) and continuous burning pain (NRS 3/10) in lower limbs; dynamic mechanic allodyniaSpastic paraparesisNone313 months154
3NANANANA9 months/6
4Grimacing and limb movements after pain stimulation of lower limbs; no reaction after upper limb stimulationSpontaneous limb movements, pyramidal signs.None39 months4-5-1 (global aphasia)5
5NoneLeft hemiparesisNone49 months153
6Not assessableSpastic tetraplegiaNone38 months4-3-15
7NoneNoneNone310 months151
8Sensory loss, burning pain (NRS 5/10)Spastic paraplegia, upper limb weaknessNoneNA10 months4-6-25
9Not assessableSpastic tetraplegiaOrthostatic hypotension, tachycardia, abnormal sweating, clammy skin110 months4-2-1 (VS)5
10Not assessableFlaccid tetraplegiaOrthostatic hypotension, tachycardia, abnormal sweating, clammy skinNA10 months4-1-1 (MCS)5
11NoneNoneNoneNA10 months151
12Light touch, pinprick, and vibratory sensory loss with stocking-glove distribution; burning pain at distal lower limbs (NRS 4/10)Reduced foot dorsiflexionNone39 months153
13Grimacing after pain stimulation of upper and lower limbsUpper limb extension and lower limb flexion after painful stimulationTachycardia, abnormal sweatingNA8 months4-2-1 (MCS)5
14NoneRight hemiparesisNone48 months154

Table 2. Patients’ neurological findings at follow-up visit.

Finger wrinkling test: scores from 0 to 2 indicate abnormal skin wrinkling; score of 3 or 4 indicate normal skin wrinkling. GCS, Glasgow Coma Scale. mRS, modified Rankin Scale: 0= no symptoms; 1= no significant disability despite symptoms; 2, 3= mild or moderate disability; 4= moderate-to-severe disability; 5= severe disability; 6=dead. VS, vegetative state. MCS, minimally conscious state.
CSV
Download CSV

Clinical dysautonomia was observed in 3 patients, of whom 1 (no. 9) also had abnormal finger wrinkling test (table 2). The only patient with normal density of sweat gland nerve fibers at skin biopsy (no. 6) did not show any sign of systemic, cardiovascular, and peripheral dysautonomia at clinical evaluation and finger wrinkling test.

Discussion

We report the first-ever observation that critical illness can be associated with a non-length dependent degeneration of somatic and autonomic small nerve fibers. This complication developed in critically ill patients with severe infection, sepsis or MOF, and prolonged mechanical ventilation and ICU stay. In association with the degeneration of IENF, patients showed also electrophysiological evidence of acute axonopathy of large nerve fibers and acute myopathy, confirming that neuromuscular alterations of critical illness complicate the clinical course of the most severely ill patients and are not isolated events, but rather are an integral part of the process leading to multiple organ dysfunctions and failures [3].

IENF degeneration has been described in several chronic conditions, such as diabetic neuropathy [27,28], but also in acute inflammatory neuropathies, such as Guillain-Barré syndrome [11-14]. Patients with SFN typically present with neuropathic pain and reduced thermal and pain sensation but with normal strength, proprioceptive sensation, and deep tendon reflexes reflecting normal large nerve fiber functions [9,10,29,30]. At skin biopsy, reduced IENF density is typically demonstrated [30]. In our series, we found a non-length dependent degeneration of somatic IENF in all the patients, suggesting that critical illness likely affects dorsal root ganglion (DRG) neurons. Patients available for neurological examination at follow-up complained of diffuse pain and thermal and nociceptive sensory loss, a pattern typical of sensory neuronopathies [18]. DRG neurons are surrounded by fenestrated capillaries instead of a tight barrier and are therefore exposed to circulating neurotoxic factors from the bloodstream. Circulating mediators such as endotoxin, other proinflammatory agents (tumor necrosis factor-a, serotonin, and histamine) or neurotoxic factors are probably released during sepsis or systemic inflammatory response syndrome, and have been proposed in the pathogenesis of CIP, but their role remains controversial because CIP can occur in the absence of an identifiable circulating mediator [31]. Future studies should investigate these candidate neurotoxic factors for their effects on the tiny nerve fibers of the skin.

Our analyses of skin biopsies were aimed at describing morphometric and morphologic features of epidermal and dermal nerves, and did not include immunohistochemical assays of cytokines or adhesion molecule expression, which might provide clue to the underlying pathogenetic mechanisms of IENF degeneration. Increased production of pro-inflammatory cytokines has a key role in promoting the organ dysfunction during the early phase of critical illness [32], and may also increase the microvascular nerve permeability leading to formation of endoneurial and axon disruption [3,33]. Since all our patients developed infections and sepsis during the ICU stay, we hypothesize that the degeneration of IENF was caused by the same mechanisms leading to axonal degeneration of large nerve fibers and multiple organ dysfunction. This hypothesis is further supported by the strict inclusion criteria adopted, which allowed us to exclude patients at risk for neuropathy before ICU admission. In addition, we performed all skin biopsies during the ICU stay over a relatively short period of time in order to detect potential risk factors with high accuracy. Future studies should evaluate if skin accumulation of inflammatory cytokines or increased expression of adhesion molecules might play a role in IENF degeneration during critical illness.

Neuropathic pain, defined as pain caused by a disease or a lesion of the somatosensory nervous system [34], was observed in 3 patients who showed thermal and nociceptive sensory loss and burning pain associated with IENF loss. This picture was likely caused by the exclusive degeneration of small nerve fibers, because NCS were normal, therefore excluding CIP or other large fiber neuropathies. Besides degeneration of the somatic IENF, all except one patient showed a profound denervation of skin sweat glands indicating autonomic peripheral involvement. Autonomic dysfunctions were evident in 3 patients, one of whom also had abnormal finger wrinkling test. However, the impact of these abnormalities on patients’ outcome could not be assessed due to severe neurologic conditions. This result confirms previous report of autonomic dysfunction with abnormal cardiac R-R variation and sympathetic skin response in ICU patients with critical illness polyneuropathy or septic encephalopathy [35].

One major limitation of our study is the small sample of patients with no control group and the fact that accurate neurological evaluation of the sensory system at follow-up was possible only in a subset of patients. Future studies should involve larger samples of non-neurologic critical care patients. In future follow-up studies, serial skin biopsies could also be offered to patients to evaluate the natural progression of the disease and the effect of potential treatments [36]. Finally, inclusion of patients without sepsis and MOF would help to confirm if IENF degeneration is part of the process leading to MOF.

Our study could contribute in addressing some issues regarding the long-term outcome of ICU survivors. In particular, chronic pain is common and probably involves multiple pathogenetic mechanisms [6,37,38]. Our findings suggest that the degeneration of somatic and autonomic small nerve fibers is a frequent complication of critical illness and explained the persisting sensory deficits and neuropathic pain observed in some survivors. In such cases, skin biopsy is a safe, almost painless, and cheap technique that can be offered to patients for evaluating small nerve fibers.

Author Contributions

Conceived and designed the experiments: NL. Analyzed the data: NL GL. Wrote the manuscript: NL. Responsible for clinical evaluation of patients in the intensive care unit: NL NF. Performed the skin biopsies: MF NF. Responsible for neurological evaluation of patients at follow-up: MF NF AT. Reviewed the manuscript: MF NF LG BG AT RL AP GL. Responsible for data recording, storage and analysis: LG. Responsible for the neurophysiological investigations of peripheral nerves and muscles: BG. Responsible for the laboratory investigations on skin biopsies: RL GL. Contributed in the analysis and interpretation of results: AP.

References

  1. 1. Iwashyna TJ (2010) Survivorship will be the defining challenge of critical care in the 21st century. Ann Intern Med 153: 204-205. doi:https://doi.org/10.7326/0003-4819-153-3-201008030-00013. PubMed: 20679565.
  2. 2. Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C et al. (2012) Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders’ conference. Crit Care Med 40: 502-509. doi:https://doi.org/10.1097/CCM.0b013e318232da75. PubMed: 21946660.
  3. 3. Latronico N, Bolton CF (2011) Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 10: 931-941. doi:https://doi.org/10.1016/S1474-4422(11)70178-8. PubMed: 21939902.
  4. 4. Guarneri B, Bertolini G, Latronico N (2008) Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg, Psychiatry 79: 838-841. doi:https://doi.org/10.1136/jnnp.2007.142430. PubMed: 18339730.
  5. 5. Latronico N, Shehu I, Seghelini E (2005) Neuromuscular sequelae of critical illness. Curr Opin Crit Care 11: 381-390. doi:https://doi.org/10.1097/01.ccx.0000168530.30702.3e. PubMed: 16015120.
  6. 6. Angel MJ, Bril V, Shannon P, Herridge MS (2007) Neuromuscular function in survivors of the acute respiratory distress syndrome. Can J Neurol Sci 34: 427-432. PubMed: 18062450.
  7. 7. Misak CJ (2011) ICU-acquired weakness: obstacles and interventions for rehabilitation. Am J Respir Crit Care Med 183: 845-846. doi:https://doi.org/10.1164/rccm.201007-1110OE. PubMed: 20971828.
  8. 8. Sommer C, Lauria G (2007) Skin biopsy in the management of peripheral neuropathy. Lancet Neurol 6: 632-642. doi:https://doi.org/10.1016/S1474-4422(07)70172-2. PubMed: 17582363.
  9. 9. Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R et al. (2008) The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 131: 1912-1925. doi:https://doi.org/10.1093/brain/awn093. PubMed: 18524793.
  10. 10. Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, et al. (2012) Gain of function Na(V) 1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 71: 26-39. doi:https://doi.org/10.1002/ana.22485. PubMed: 21698661.
  11. 11. Seneviratne U, Gunasekera S (2002) Acute small fibre sensory neuropathy: another variant of Guillain-Barre syndrome? J Neurol Neurosurg, Psychiatry 72: 540-542.
  12. 12. Pan CL, Tseng TJ, Lin YH, Chiang MC, Lin WM et al. (2003) Cutaneous innervation in Guillain-Barre syndrome: pathology and clinical correlations. Brain 126: 386-397. doi:https://doi.org/10.1093/brain/awg039. PubMed: 12538405.
  13. 13. Martinez V, Fletcher D, Martin F, Orlikowski D, Sharshar T et al. (2010) Small fibre impairment predicts neuropathic pain in Guillain-Barre syndrome. Pain 151: 53-60. doi:https://doi.org/10.1016/j.pain.2010.05.017. PubMed: 20696121.
  14. 14. Ruts L, van Doorn PA, Lombardi R, Haasdijk ED, Penza P et al. (2012) Unmyelinated and myelinated skin nerve damage in Guillain-Barre syndrome: correlation with pain and recovery. Pain 153: 399-409. doi:https://doi.org/10.1016/j.pain.2011.10.037. PubMed: 22154920.
  15. 15. Chiang MC, Lin YH, Pan CL, Tseng TJ, Lin WM et al. (2002) Cutaneous innervation in chronic inflammatory demyelinating polyneuropathy. Neurology 59: 1094-1098. doi:https://doi.org/10.1212/WNL.59.7.1094. PubMed: 12370473.
  16. 16. Üçeyler N, Zeller D, Kahn AK, Kewenig S, Kittel-Schneider S et al. (2013) Small fibre pathology in patients with fibromyalgia syndrome. Brain 136: 1857-1867. doi:https://doi.org/10.1093/brain/awt053. PubMed: 23474848.
  17. 17. Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P et al. (2010) Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 15: 202-207. doi:https://doi.org/10.1111/j.1529-8027.2010.00271.x. PubMed: 21040142.
  18. 18. Sghirlanzoni A, Pareyson D, Lauria G (2005) Sensory neuron diseases. Lancet Neurol 4: 349-361. doi:https://doi.org/10.1016/S1474-4422(05)70096-X. PubMed: 15907739.
  19. 19. Ruts L, van Doorn PA, Lombardi R, Haasdijk ED, Penza P et al. (2012) Unmyelinated and myelinated skin nerve damage in Guillain-Barré syndrome: correlation with pain and recovery. Pain 153: 399-409. doi:https://doi.org/10.1016/j.pain.2011.10.037. PubMed: 22154920.
  20. 20. Latronico N, Bertolini G, Guarneri B, Botteri M, Peli E et al. (2007) Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study. Crit Care 11: R11. doi:https://doi.org/10.1186/cc5171. PubMed: 17254336.
  21. 21. Zamperetti N, Latronico N (2008) Clinical research in critically ill patients: the situation in Italy. Intensive Care Med 34: 1330-1332. doi:https://doi.org/10.1007/s00134-008-1096-6. PubMed: 18389217.
  22. 22. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34: 17-60. doi:https://doi.org/10.1007/s00134-007-0934-2. PubMed: 18058085.
  23. 23. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL (2001) Serial evaluation of the SOFA score to predict outcome in critically ill patients. J Am Med Assoc 286: 1754-1758. doi:https://doi.org/10.1001/jama.286.14.1754. PubMed: 11594901.
  24. 24. Teoh HL, Chow A, Wilder-Smith EP (2008) Skin wrinkling for diagnosing small fibre neuropathy: comparison with epidermal nerve density and sympathetic skin response. J Neurol Neurosurg, Psychiatry 79: 835-837. doi:https://doi.org/10.1136/jnnp.2007.140947. PubMed: 18270233.
  25. 25. Wilder-Smith EP, Guo Y, Chow A (2009) Stimulated skin wrinkling for predicting intraepidermal nerve fibre density. Clin Neurophysiol 120: 953-958. doi:https://doi.org/10.1016/j.clinph.2009.03.011. PubMed: 19375384.
  26. 26. Lauria G, Borgna M, Morbin M, Lombardi R, Mazzoleni G et al. (2004) Tubule and neurofilament immunoreactivity in human hairy skin: markers for intraepidermal nerve fibers. Muscle Nerve 30: 310-316. doi:https://doi.org/10.1002/mus.20098. PubMed: 15318342.
  27. 27. Krämer HH, Rolke R, Bickel A, Birklein F (2004) Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care 27: 2386-2391. doi:https://doi.org/10.2337/diacare.27.10.2386. PubMed: 15451905.
  28. 28. Sorensen L, Molyneaux L, Yue DK (2006) The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 29: 883-887. doi:https://doi.org/10.2337/diacare.29.04.06.dc05-2180. PubMed: 16567832.
  29. 29. England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ et al. (2009) Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 72: 177-184. doi:https://doi.org/10.1212/01.wnl.0000336345.70511.0f. PubMed: 19056667.
  30. 30. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM et al. (2010) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol Off J Eur Fed Neurol Soc 17: 903-912.
  31. 31. Batt J, dos Santos CC, Cameron JI, Herridge MS (2013) Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med 187: 238-246. doi:https://doi.org/10.1164/rccm.201205-0954SO. PubMed: 23204256.
  32. 32. Singer M, De Santis V, Vitale D, Jeffcoate W (2004) Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 364: 545-548. doi:https://doi.org/10.1016/S0140-6736(04)16815-3. PubMed: 15302200.
  33. 33. Fenzi F, Latronico N, Refatti N, Rizzuto N (2003) Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol (Berl) 106: 75-82. PubMed: 12698264.
  34. 34. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO et al. (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70: 1630-1635. doi:https://doi.org/10.1212/01.wnl.0000282763.29778.59. PubMed: 18003941.
  35. 35. Bolton C, Thompson J, Bernardi L, Voll C, Young B (2007) The cardiac R-R variation and sympathetic skin response in the intensive care unit. Can J Neurol Sci 34: 313-315. PubMed: 17803028.
  36. 36. Lauria G, Lombardi R (2007) Skin biopsy: a new tool for diagnosing peripheral neuropathy. Bmj 334: 1159-1162. doi:https://doi.org/10.1136/bmj.39192.488125.BE. PubMed: 17540945.
  37. 37. Kyranou M, Puntillo K (2012) The transition from acute to chronic pain: might intensive care unit patients be at risk? Ann Intensive Care 2: 36. doi:https://doi.org/10.1186/2110-5820-2-36. PubMed: 22898192.
  38. 38. Battle CE, Lovett S, Hutchings H (2013) Chronic pain in survivors of critical illness: a retrospective analysis of incidence and risk factors. Crit Care 17: R101. doi:https://doi.org/10.1186/cc12746. PubMed: 23718685.